癌症发病和药理学中的性别和性别差异
Beatriz Bernardez1,2,3, Oliver Higuera4, Virginia Martinez-Callejo5
1Departament of Medicine and Pharmacology Group, University of Santiago de Compostela, Santiago de Compostela, Spain.
概括
性和性别显著影响癌症. 男性和女性之间存在发病率,死亡率和生存率的差异,影响治疗疗效和治疗结果.
科学领域:
- 在瘤学瘤学.
- 医学科学 医学科学 医学科学
- 公共卫生 公共卫生
背景情况:
- 性别和性别影响癌症流行病学,病变发生和预后.
- 在男性和女性之间观察到癌症发病率和死亡率的差异.
- 这些差异延伸到癌症治疗的药理动力学和药理动力学.
研究的目的:
- 审查癌症流行病学和发病过程中的性别和性别差异.
- 探索这些差异对癌症治疗的影响.
- 强调在癌症研究和临床实践中考虑性别和性别的重要性.
主要方法:
- 现有文献的叙述性审查.
- 对癌症发病率,死亡率和性别生存率的流行病学数据的分析.
- 检查导致性别和性别差异的生物学和行为因素.
- 关于癌症药物药理动力学和药理动力学性别差异的研究综述.
主要成果:
- 大多数癌症 (不包括生殖相关的癌症) 在男性中发生率较高;胆囊和甲状腺癌在女性中更为常见.
- 男性的癌症死亡率更高,而女性的生存率更高.
- 身体组成,生理学和受体表达的性别和性别差异影响癌症治疗.
- 行为因素和检测差异也导致观察到的差异.
结论:
- 性别和性别是癌症诊断,亚型,预后和治疗中的关键变量.
- 个性化癌症护理必须考虑性别和性别,以优化结果.
- 需要进一步的研究,以充分阐明和解决癌症中的性别和性别差异.
更多相关视频
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
6.3K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
12.9K
相关概念视频
Cancer
47.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.2K
Cancer Survival Analysis
311
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
311
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
